window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : April 25, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Drug Development

  • Biotech,Clinical Trials,Drug Development,Oncology,Precision medicine,Research & Development

    NETRIS Pharma Nature publishes pancreatic cancer Phase 1b data showing NP137 survival and surgery gains

    Nature publishes Phase 1b data showing NETRIS Pharma’s NP137 improves [...]

    April 24, 2026
  • Drug Delivery & Formulation,Drug Development,Oncology,Pharmaceuticals and therapeutics,Research & Development,Technology and platforms

    ISS National Lab research advances DNA-inspired cancer nanomaterials for chemotherapy and immunotherapy development

    Eascra Biotech is advancing DNA-inspired nanomaterials developed with ISS National [...]

    April 18, 2026
  • CDMOs & Manufacturing,Drug Development,European biotech,Logistics and distribution,Oncology,Partnerships & Funding,Supply Chain & Logistics

    Oncodesign expands ARRONAX deal to secure astatine-211 supply for radiotherapy research

    Oncodesign Services has expanded its collaboration with French research institute [...]

    April 18, 2026
  • Biomanufacturing,CDMOs & Manufacturing,Drug Development,Manufacturing,Pharmaceuticals and therapeutics,Supply Chain & Logistics

    Pharma firms localise GLP-1 supply chains as shortages and geopolitical risks grow

    Drugmakers are regionalising GLP-1 manufacturing as demand surges, shortages persist [...]

    April 17, 2026
  • Clinical Development,Drug Development,FDA,Neurosciences,Pharmaceuticals and therapeutics,Rare Diseases

    Emalex wins US patent for ecopipam ODT as Tourette access program grows

    Emalex has secured a US patent for an orally disintegrating [...]

    April 17, 2026
  • Central Nervous System,Clinical Development,Drug Delivery & Formulation,Drug Development,Neurosciences,Patient Centricity

    Emalex secures US patent for ecopipam orally disintegrating tablet in Tourette syndrome

    Emalex Biosciences has secured a US patent for an orally [...]

    April 11, 2026
  • Artificial Intelligence,Biotech,Drug Development,Drug discovery,Research & Development

    ProQR partners with Ginkgo Bioworks for AI-driven RNA editing development and forms advisory board

    ProQR Therapeutics has entered a collaboration with Ginkgo Bioworks to [...]

    April 9, 2026
  • Artificial Intelligence,Drug Development,Drug discovery,Research & Development,Technology and platforms

    William Blair highlights Carterra as key player in AI-driven drug discovery shift

    A new analyst report from William Blair has highlighted Carterra [...]

    April 9, 2026
  • Biomanufacturing,Cell & Gene Therapy,Drug Development,Manufacturing,Partnerships & Funding

    Virica and Fujifilm target AAV manufacturing bottleneck with enhancer collaboration

    Scaling production of adeno-associated virus vectors remains a key barrier [...]

    April 9, 2026
  • Clinical Development,Drug Development,Healthcare leadership,Movers & Shakers,Neurosciences,Oncology,Rare Diseases

    Allucent adds strategy leaders to expand therapeutic expertise

    Allucent has appointed new therapeutic strategy leaders across key disease [...]

    April 9, 2026
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Neomorph raises $100 million to advance NEO-811 Phase 1/2 cancer trial and molecular glue degrader pipeline
    Categories: Biotech, Clinical Trials, Drug discovery, Funding, Oncology, Partnerships & Funding, Pharmaceuticals and therapeutics, Research & Development, Technology and platforms
  • NICE expands Lokelma access for hyperkalaemia after draft recommendation
    Categories: Cardiovascular diseases, Chronic diseases, Market Access & Commercialization, Pharmaceuticals and therapeutics, Regulatory Affairs
  • Oncodesign expands ARRONAX deal to secure astatine-211 supply for radiotherapy research
    Categories: CDMOs & Manufacturing, Drug Development, European biotech, Logistics and distribution, Oncology, Partnerships & Funding, Supply Chain & Logistics
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top